Concepedia

Author

Marilin Koch

University of TübingenORCID

Also Known As

M. Koch, Marilin Koch, Marilin S Koch, Marilin S. Koch, Marilin Sophia Koch

30

Publications

468

Citations

10

H-Index

27

Concepts

All Affiliations

University of TübingenHertie Institute for Clinical Brain ResearchBrigham and Women's HospitalHarvard UniversityJena University Hospital
MK

About

Marilin Koch is an author at University of Tübingen specializing in medicine, neurology, and peripheral nerves.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

218

2

Neurology

2

2

136

3

Health Sciences

1

1

82

4

Cell Biology

1

1

82

5

Immunology

1

1

82

Marilin Koch

×

9

Publications

386

Citations

9

H-Index

YearCitations

Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy—a Prospective Follow-Up

Florian Härtig, Marlene Ross, Nele Dammeier,

Neurotherapeutics

2018

88

Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma

Justyna M. Przystal, Hannes Becker, Denis Canjuga,

Cancers

2021

82

A look inside the nerve – Morphology of nerve fascicles in healthy controls and patients with polyneuropathy

Alexander Grimm, Natalie Winter, Tim W. Rattay,

Clinical Neurophysiology

2017

48

Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma

Srinath Rajaraman, Denis Canjuga, Michael Ghosh,

Molecular Therapy — Oncolytics

2018

47

Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma

Marilin Koch, Mykola Zdioruk, Michal O. Nowicki,

Molecular Therapy — Oncolytics

2022

39

Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma

Marco Skardelly, Elena Dangel, Julia Gohde,

The Oncologist

2017

32

Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models

Marilin Koch, Mykola Zdioruk, Michal O. Nowicki,

Journal for ImmunoTherapy of Cancer

2022

26

Low FoxG1 and high Olig‐2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)‐mutant gliomas

Sarah K. Schäfer, Felix Behling, Marco Skardelly,

Neuropathology and Applied Neurobiology

2017

13

PPRX-1701, a nanoparticle formulation of 6′-bromoindirubin acetoxime, improves delivery and shows efficacy in preclinical GBM models

Mykola Zdioruk, Jorge-Luis Jimenez-Macias, Michal O. Nowicki,

Cell Reports Medicine

2023

11

Page 1